Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-005424-33Phase 4Active
Phase 4, randomised trial of remifentanil (2 arms), sponsored by OLVG West. Primary endpoint: Patient satisfaction. Started Oct 2007; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-005424-33.